These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10608350)

  • 1. Neuregulin receptor-mediated gene transfer by human epidermal growth factor receptor 2-targeted antibodies and neuregulin-1.
    Kern JA; Wakita R; Sliwkowski MX
    Cancer Gene Ther; 1999; 6(6):537-45. PubMed ID: 10608350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated gene delivery using the Fab fragments of anti-epidermal growth factor receptor antibodies: improved immunogene approach.
    Chen J; Gamou S; Takayanagi A; Ohtake Y; Ohtsubo M; Shimizu N
    Cancer Gene Ther; 1998; 5(6):357-64. PubMed ID: 9917090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro.
    Patel NV; Acarregui MJ; Snyder JM; Klein JM; Sliwkowski MX; Kern JA
    Am J Respir Cell Mol Biol; 2000 Apr; 22(4):432-40. PubMed ID: 10745024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N; Jain A; Kawamata N; Popoviciu LM; Said JW; Whittaker S; Miyakawa I; Agus DB; Koeffler HP
    Cancer; 2005 Dec; 104(12):2701-8. PubMed ID: 16265675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.
    Fendly BM; Winget M; Hudziak RM; Lipari MT; Napier MA; Ullrich A
    Cancer Res; 1990 Mar; 50(5):1550-8. PubMed ID: 1689212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin-1-mediated autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers.
    Wilson TR; Lee DY; Berry L; Shames DS; Settleman J
    Cancer Cell; 2011 Aug; 20(2):158-72. PubMed ID: 21840482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.
    Aigner A; Juhl H; Malerczyk C; Tkybusch A; Benz CC; Czubayko F
    Oncogene; 2001 Apr; 20(17):2101-11. PubMed ID: 11360194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling.
    Wong TW; Lee FY; Yu C; Luo FR; Oppenheimer S; Zhang H; Smykla RA; Mastalerz H; Fink BE; Hunt JT; Gavai AV; Vite GD
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6186-93. PubMed ID: 17062696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
    Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
    Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.
    Mendoza N; Phillips GL; Silva J; Schwall R; Wickramasinghe D
    Cancer Res; 2002 Oct; 62(19):5485-8. PubMed ID: 12359757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marked enhancement in gene expression by targeting the human insulin receptor.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Feb; 5(2):157-63. PubMed ID: 12539153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA.
    Fregien NL; White LA; Bunge MB; Wood PM
    Glia; 2005 Jan; 49(1):24-35. PubMed ID: 15390106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
    Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
    Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2-targeted gene transfer.
    Foster BJ; Kern JA
    Hum Gene Ther; 1997 Apr; 8(6):719-27. PubMed ID: 9113511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of the monoclonal antibody 4B5 in breast tissue expressing human epidermal growth factor receptor 4 (HER4).
    Jay JI; Brunhoeber PS; Smith MH; Williams RR; Sugarman MC; Free HL; Tast DE
    Histopathology; 2013 Mar; 62(4):563-77. PubMed ID: 23432624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localisation of Neuregulin 1-β3 to different sub-nuclear structures alters gene expression.
    Wang M; Trim CM; Gullick WJ
    Exp Cell Res; 2011 Feb; 317(4):423-32. PubMed ID: 21110958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients.
    Yun S; Koh J; Nam SK; Park JO; Lee SM; Lee K; Lee KS; Ahn SH; Park DJ; Kim HH; Choe G; Kim WH; Lee HS
    Gastric Cancer; 2018 Mar; 21(2):225-236. PubMed ID: 28573357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
    Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
    Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.